Home › Hodgkin Lymphoma
Hodgkin Lymphoma clinical trials recruiting in the U.S.
63 studies for Hodgkin Lymphoma are recruiting participants at sites across the United States.
Hodgkin lymphoma is a type of lymphoma, cancer of the lymph system. It is serious but can usually be cured if found and treated early. Learn more.
Cities with the most studies
- Houston, TX14 studies
- New York City, NY11 studies
- Boston, MA9 studies
- Baldwin Park, CA9 studies
- Miami, FL8 studies
- Memphis, TN7 studies
- Mountain View, CA6 studies
- Philadelphia, PA6 studies
- Atlanta, GA5 studies
- Greenburgh, NY5 studies
- Washington, DC4 studies
- Queens, NY4 studies
- Edison, NJ4 studies
- Milwaukee, WI4 studies
- Madison, WI4 studies
- Aurora, CO4 studies
- Durham, NC4 studies
- Birmingham, AL3 studies
- Staten Island, NY3 studies
- New Rochelle, NY3 studies
- East Norwalk, CT3 studies
- Denver, CO3 studies
- Los Angeles, CA3 studies
- Sacramento, CA3 studies
- San Francisco, CA3 studies
- Cincinnati, OH3 studies
- Columbus, OH3 studies
- Chicago, IL3 studies
- Seattle, WA3 studies
- Orange, CA3 studies
- Baltimore, MD3 studies
- Indianapolis, IN3 studies
- Minneapolis, MN3 studies
By state
- Alabama3 studies
- California16 studies
- Colorado5 studies
- Florida12 studies
- Georgia7 studies
- Illinois4 studies
- Indiana4 studies
- Maryland5 studies
- Massachusetts9 studies
- Minnesota5 studies
- New Jersey5 studies
- New York15 studies
- North Carolina6 studies
- Ohio4 studies
- Pennsylvania7 studies
- Tennessee8 studies
- Texas15 studies
- Washington4 studies
- Wisconsin8 studies
Recently updated studies
Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT05272384Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols
RecruitingObservational study
Ages 18 to 120 · All sexes · Updated Nov 12, 2026 · NCT02682667Patient-Reported Outcomes and Quality of Life in Adult and Pediatric Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
RecruitingObservational study
Ages 8 and older · All sexes · Updated Nov 10, 2026 · NCT06098430Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 10, 2026 · NCT03618550A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT06150664Auto Stem Cell Transplant for Lymphoma Patients
RecruitingPhase 2
Up to age 75 · All sexes · Updated Nov 4, 2026 · NCT03125642Personalized NK Cell Therapy in CBT
RecruitingPhase 2
Ages 15 to 80 · All sexes · Updated Nov 2, 2026 · NCT02727803Nivolumab With Ruxolitinib in Relapsed or Refractory Classical Hodgkin Lymphoma
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Nov 2, 2026 · NCT03681561Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
RecruitingObservational study
Ages 0 to 38 · All sexes · Updated Oct 29, 2026 · NCT06131801Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
RecruitingObservational study
Ages 18 to 120 · All sexes · Updated Oct 28, 2026 · NCT01137643Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
RecruitingPhase 1
7 Months – 21 Years · All sexes · Updated Oct 27, 2026 · NCT02508038Tissue Collection for Studies of Lymph Cancer
RecruitingObservational study
Ages 18 and older · All sexes · Updated Oct 26, 2026 · NCT01676805CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant
RecruitingPhase 2Healthy volunteers welcome
Ages 18 to 75 · All sexes · Updated Oct 23, 2026 · NCT06059391AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion
RecruitingPhase 2
1 Day – 30 Years · All sexes · Updated Oct 23, 2026 · NCT04099966A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 75 · All sexes · Updated Oct 23, 2026 · NCT07020533ctDNA-Guided Therapy for Relapsed/Refractory Hodgkin Lymphoma
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 20, 2026 · NCT07021989Wisconsin Ginseng for Decreasing Cancer Related Fatigue
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 20, 2026 · NCT06395441AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
RecruitingPhase 1/2
Ages 12 and older · All sexes · Updated Oct 13, 2026 · NCT06137144Establishing a Tumor Bank in Families With Multiple Lymphoproliferative Malignancies
RecruitingObservational study
Ages 18 and older · All sexes · Updated Oct 13, 2026 · NCT00131014Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Bone Marrow or Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
RecruitingEarly phase 1
Ages 18 and older · All sexes · Updated Oct 5, 2026 · NCT06398457Constitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive Lymphomas
RecruitingPhase 1
Ages 12 to 75 · All sexes · Updated Oct 2, 2026 · NCT06176690CD30 CAR T Cells, Relapsed CD30 Expressing Lymphoma (RELY-30)
RecruitingPhase 1
Ages 12 to 75 · All sexes · Updated Oct 2, 2026 · NCT02917083The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT07285044Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT03418038A Phase II Trial of Mosunetuzumab, Polatuzumab, Tafasitamab, and Lenalidomide in Patients With Relapsed B-cell NHL
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT05615636From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.